COYA THERAPEUTICS INC(NASDAQ:COYA) stock News

COYA Latest News, Press Relases and Analysis

All

Press Releases

13 hours ago - By: Coya Therapeutics, Inc.

Coya Therapeutics Announces Publication of Scientific Research Linking Inflammation and Oxidative Stress to the Progression of Parkinson’s Disease

3 days ago - By: Coya Therapeutics, Inc.

Coya Therapeutics to Participate in the BTIG Virtual Biotechnology Conference July 29 – 30, 2025

a month ago - By: ACCESS Newswire - Mentions: INUV DGXX DGX.CA SURG ...

Updated Lineup Announced for iAccess Alpha's Virtual Summer Investment Conference, June 24–25, 2025

4 months ago - By: Zacks Investment Research - Mentions: AUNA

Are Medical Stocks Lagging Auna S.A. (AUNA) This Year?

a month ago - By: ACCESS Newswire - Mentions: INUV DGXX DGX.CA SURG ...

iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 24-25, 2025

a month ago - By: Coya Therapeutics, Inc.

Coya Therapeutics to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24 – 25, 2025

2 months ago - By: Coya Therapeutics, Inc.

Coya Therapeutics Announces Issuance of New U.S. Patent Protecting Methods of Producing Recombinant Human (rh) Interleukin-2 (aldesleukin) Liquid Formulations

2 months ago - By: Coya Therapeutics, Inc.

Coya Therapeutics to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

2 months ago - By: Coya Therapeutics, Inc.

Coya Therapeutics Reports First Quarter Financial Results and Provides a Corporate Update

3 months ago - By: Coya Therapeutics, Inc.

Coya Therapeutics to Participate in Two Upcoming Conferences in May 2025

3 months ago - By: Benzinga - Mentions: BTMD MSFT TRNR QCOM ...

Why Meta Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

3 months ago - By: Zacks Investment Research - Mentions: DOCS

Is Coya Therapeutics, Inc. (COYA) Outperforming Other Medical Stocks This Year?

3 months ago - By: Coya Therapeutics, Inc.

Coya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with Mild to Moderate Frontotemporal Dementia

3 months ago - By: Zacks Investment Research

Wall Street Analysts See a 144.73% Upside in Coya Therapeutics, Inc. (COYA): Can the Stock Really Move This High?

3 months ago - By: Coya Therapeutics, Inc.

Coya Therapeutics Announces Publication of GLP-1/LD IL-2 Combination Biologic (COYA 303) Demonstrating Synergistic Enhancement of Regulatory T Cell Function and Protection Against Treg Apoptosis (Cell Death)

3 months ago - By: Atea Pharmaceuticals, Inc. - Mentions: AVIR

Atea Pharmaceuticals Appoints Howard H. Berman to Board of Directors and Announces Share Repurchase Program

3 months ago - By: Yahoo Finance - Mentions: KC HTGC CNC AVDX ...

Why Kingsoft Cloud Holdings Limited (KC) Surged On Friday?

3 months ago - By: Yahoo Finance - Mentions: GLPG GLRE CNC GANX ...

Is Galapagos (GLPG) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?

3 months ago - By: Yahoo Finance - Mentions: GLRE KC GANX LOAR ...

Is Coya Therapeutics (COYA) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?

3 months ago - By: Yahoo Finance - Mentions: GANX GLRE CNC EGY ...

Is Gain Therapeutics (GANX) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?

3 months ago - By: Yahoo Finance - Mentions: NAT GES XOM ACMR ...

Nordic American Tankers Limited (NAT): One of the High-Dividend Stocks to Invest In Under $10

4 months ago - By: Benzinga - Mentions: SGMO IBO ALDX BBLG ...

12 Health Care Stocks Moving In Thursday's After-Market Session

4 months ago - By: Coya Therapeutics, Inc.

Coya Therapeutics Selected for Platform Presentation at the ADPD 2025 Conference in Vienna on April 5, 2025

4 months ago - By: Zacks Investment Research

What Makes Coya Therapeutics, Inc. (COYA) a New Buy Stock

4 months ago - By: Zacks Investment Research

Wall Street Analysts Think Coya Therapeutics, Inc. (COYA) Could Surge 149.62%: Read This Before Placing a Bet

4 months ago - By: Coya Therapeutics, Inc.

Coya Therapeutics Reports Progress from an Academic Supported First-in-Class Treg-derived Exosome Program

4 months ago - By: Coya Therapeutics, Inc.

Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2024 Financial Results

5 months ago - By: Coya Therapeutics, Inc.

Coya Therapeutics to Participate in KOL Call Hosted by BTIG to Discuss the Potential Treatment of Alzheimer’s Disease Using GLP-1 Agonists and Combinations

6 months ago - By: Coya Therapeutics, Inc.

Coya Therapeutics Reports Statistically Significant Improvement of Inflammatory Blood Markers in Patients with Alzheimer’s Disease Following Monthly Dosing with Low-Dose IL-2, Further Supporting Clinical Development

6 months ago - By: Coya Therapeutics, Inc.

Coya Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

6 months ago - By: Coya Therapeutics, Inc.

Coya Therapeutics Announces Pipeline Expansion - COYA 303: COYA 301 in Combination with GLP-1 Receptor Agonist for the Treatment of Inflammatory Diseases

7 months ago - By: Coya Therapeutics, Inc.

Coya Therapeutics Provides Enrollment Update of the Investigator-Initiated Phase 1 Study of Low Dose Interleukin-2 (LD IL-2) + CTLA4-Ig Fusion Protein in Patients with Frontotemporal Dementia (FTD)

8 months ago - By: Coya Therapeutics, Inc.

Coya Therapeutics to Participate in a Fireside Chat at the 7th Annual Evercore HealthCONx Conference

8 months ago - By: Coya Therapeutics, Inc.

Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders

9 months ago - By: Coya Therapeutics, Inc.

Coya Therapeutics Provides a Corporate Update and Reports Unaudited Third Quarter 2024 Financial Results

9 months ago - By: Coya Therapeutics, Inc.

COYA THERAPEUTICS INC (COYA) Stock News

COYA Latest News, Press Relases and Analysis

Coya Therapeutics Announces Publication of Scientific Research Linking Inflammation and Oxidative Stress to the Progression of Parkinson’s Disease

Coya Therapeutics to Participate in the BTIG Virtual Biotechnology Conference July 29 – 30, 2025

Updated Lineup Announced for iAccess Alpha's Virtual Summer Investment Conference, June 24–25, 2025

Are Medical Stocks Lagging Auna S.A. (AUNA) This Year?

iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 24-25, 2025

Coya Therapeutics to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24 – 25, 2025

Coya Therapeutics Announces Issuance of New U.S. Patent Protecting Methods of Producing Recombinant Human (rh) Interleukin-2 (aldesleukin) Liquid Formulations

Coya Therapeutics to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

Coya Therapeutics Reports First Quarter Financial Results and Provides a Corporate Update

Coya Therapeutics to Participate in Two Upcoming Conferences in May 2025

Why Meta Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

Is Coya Therapeutics, Inc. (COYA) Outperforming Other Medical Stocks This Year?

Coya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with Mild to Moderate Frontotemporal Dementia

Wall Street Analysts See a 144.73% Upside in Coya Therapeutics, Inc. (COYA): Can the Stock Really Move This High?

Coya Therapeutics Announces Publication of GLP-1/LD IL-2 Combination Biologic (COYA 303) Demonstrating Synergistic Enhancement of Regulatory T Cell Function and Protection Against Treg Apoptosis (Cell Death)

Atea Pharmaceuticals Appoints Howard H. Berman to Board of Directors and Announces Share Repurchase Program

Why Kingsoft Cloud Holdings Limited (KC) Surged On Friday?

Is Galapagos (GLPG) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?

Is Coya Therapeutics (COYA) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?

Is Gain Therapeutics (GANX) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?

Nordic American Tankers Limited (NAT): One of the High-Dividend Stocks to Invest In Under $10

12 Health Care Stocks Moving In Thursday's After-Market Session

Coya Therapeutics Selected for Platform Presentation at the ADPD 2025 Conference in Vienna on April 5, 2025

What Makes Coya Therapeutics, Inc. (COYA) a New Buy Stock

Wall Street Analysts Think Coya Therapeutics, Inc. (COYA) Could Surge 149.62%: Read This Before Placing a Bet

Coya Therapeutics Reports Progress from an Academic Supported First-in-Class Treg-derived Exosome Program

Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2024 Financial Results

Coya Therapeutics to Participate in KOL Call Hosted by BTIG to Discuss the Potential Treatment of Alzheimer’s Disease Using GLP-1 Agonists and Combinations

Coya Therapeutics Reports Statistically Significant Improvement of Inflammatory Blood Markers in Patients with Alzheimer’s Disease Following Monthly Dosing with Low-Dose IL-2, Further Supporting Clinical Development

Coya Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Coya Therapeutics Announces Pipeline Expansion - COYA 303: COYA 301 in Combination with GLP-1 Receptor Agonist for the Treatment of Inflammatory Diseases

Coya Therapeutics Provides Enrollment Update of the Investigator-Initiated Phase 1 Study of Low Dose Interleukin-2 (LD IL-2) + CTLA4-Ig Fusion Protein in Patients with Frontotemporal Dementia (FTD)

Coya Therapeutics to Participate in a Fireside Chat at the 7th Annual Evercore HealthCONx Conference

Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders

Coya Therapeutics Provides a Corporate Update and Reports Unaudited Third Quarter 2024 Financial Results

Coya Therapeutics Announces Arun Swaminathan, Ph.D. Assumes New Role as Chief Executive Officer